BAX and colorectal carcinoma: Western blot analysis showed that only the synergistic combination of everolimus plus AZA significantly increased Bax with a concomitant decrease in Bcl2 expression, while there was no significant change in the expression of these proteins after the exposure of MZ‐CRC‐1 cells to everolimus or AZA alone (Fig. 8).